Items | Total (n=489) | Physicians (n=67) | General neurologists (n=344) | Movement disorders specialists (n=78) | P value |
---|---|---|---|---|---|
Age < 65 years without cognitive impairment | |||||
Levodopa | 164(33.5%) | 28(41.8%) | 114(33.1%) | 22(28.2%) | 0.216 |
Dopamine agonists | 210(42.9%) | 13(19.4%) | 144(41.9%) | 53(67.9%) | 0.000 |
MAO-B inhibitors | 62(12.7%) | 8(11.9%) | 37(10.8%) | 17(21.8%) | 0.030 |
Age > 65 years or with cognitive impairment | |||||
Levodopa | 277(56.6%) | 30(44.8%) | 192(55.8%) | 55(70.5%) | 0.007 |
Dopamine agonists | 114(23.3%) | 8(11.9%) | 80(23.3%) | 26(33.3%) | 0.01 |
MAO-B inhibitors | 41(8.4%) | 7(10.4%) | 26(7.6%) | 8(10.3%) | 0.597 |
Wearing-off phenomenon | |||||
Add levodopa frequency | 187(38.2%) | 14(20.9%) | 131(38.1%) | 42(53.8%) | 0.000 |
Switch to CR levodopa | 236(48.3%) | 15(22.4%) | 173(50.3%) | 48(61.5%) | 0.000 |
Add COMT inhibitors or MAO-B inhibitors | 203(41.5%) | 21(31.3%) | 136(39.5%) | 46(59.0%) | 0.001 |
Add dopamine agonists | 196(40.1%) | 15(22.4%) | 143(41.6%) | 38(48.7%) | 0.003 |
Peak-dose dyskinesia | |||||
Reduce levodopa dose, add its frequency | 218(44.6%) | 24(35.8%) | 149(43.3%) | 45(57.7%) | 0.021 |
Reduce levodopa dose, add dopamine agonists | 215(44.0%) | 15(22.4%) | 151(43.9%) | 49(62.8%) | 0.000 |
Reduce levodopa dose, add COMT inhibitors | 145(29.7%) | 15(22.4%) | 97(28.2%) | 33(42.3%) | 0.018 |
Add amantadine | 71(14.5%) | 8(11.9%) | 38(11.0%) | 25(32.1%) | 0.000 |
PD with psychosis | |||||
Clozapine | 112(22.9%) | 11(16.4%) | 67(19.5%) | 34(43.6%) | 0.000 |
Olanzapine | 224(45.8%) | 27(40.3%) | 162(47.1%) | 35(44.9%) | 0.584 |
Quetiapine | 106(21.7%) | 9(13.4%) | 68(19.8%) | 29(37.2%) | 0.001 |
PD with dementia | |||||
Huperzine A | 124(25.4%) | 8(11.9%) | 101(29.3%) | 15(19.2%) | 0.004 |
Donepezil | 263(53.8%) | 30(44.8%) | 178(51.7%) | 55(70.5%) | 0.003 |
Rivastigmine | 82(16.8%) | 10(14.9%) | 50(14.5%) | 22(28.2%) | 0.013 |
Memantine | 185(37.8%) | 15(22.4%) | 126(36.6%) | 44(56.4%) | 0.000 |
PD with depression | |||||
Tricyclic antidepressants | 101(20.7%) | 13(19.4%) | 79(23.0%) | 9(11.5%) | 0.077 |
SSRIs | 292(59.7%) | 31(46.3%) | 200(58.1%) | 61(78.2%) | 0.000 |
Pramipexole | 185(37.8%) | 16(23.9%) | 125(36.3%) | 44(56.4%) | 0.000 |
PD with RLS | |||||
Levodopa | 123(25.2%) | 11(16.4%) | 86(25.0%) | 26(33.3%) | 0.064 |
Dopamine agonists | 149(30.5%) | 15(22.4%) | 90(26.2%) | 44(56.4%) | 0.000 |
Benzodiazepines | 140(28.6%) | 15(22.4%) | 108(31.4%) | 17(21.8%) | 0.114 |